Cancer Moonshot℠ – Funding Opportunities
The funding opportunity announcements (FOAs) listed below highlight research initiatives that align with the efforts of the Cancer Moonshot. They may be supported with existing funds or with the 21st Century Cures funding.
Please note that all publications and data resulting from Cancer Moonshot funded initiatives will be required to be immediately accessible. For more information, see the Cancer Moonshot Public Access and Data Sharing Policy.
| BRP Recommendation | Title | Announcement Number | Receipt Date |
|---|---|---|---|
| New Enabling Cancer Technologies | Spatial Sequencing Technologies with Single Cell Resolution for Cancer Research | PHS 2020-1/Topic 403 | 10/23/2019 |
| New Enabling Cancer Technologies | Subcellular Microscopy and -Omics in Cancer Cell Biology | PHS 2020-1/Topic 404 | 10/23/2019 |
| New Enabling Cancer Technologies | Intra-Tumor Sensing Technologies for Tumor Pharmacotyping | PHS 2020-1/Topic 405 | 10/23/2019 |
| Prevention and Early Detection | Software for Patient Navigation Through the Cancer Care Continuum | PHS 2020-1/Topic 406 | 10/23/2019 |
| National Cancer Data Ecosystem | Cloud-Based Software for the Cancer Research Data Commons | PHS 2020-1/Topic 407 | 10/23/2019 |
| Generation of Human Tumor Atlases | Tools and Technologies for Visualizing Multi-Scale Data | PHS 2020-1/Topic 408 | 10/23/2019 |
| Network for Patient Engagement | Cancer Clinical Trials Recruitment and Retention Tools for Participant Engagement | PHS 2020-1/Topic 410 | 10/23/2019 |
| Symptom Management Research | Software Enabling Data Integration from Wearable Sensors for Cancer Patients | PHS 2020-1/Topic 412 | 10/23/2019 |
| Direct Patient Engagement Network | Patient Engagement and Cancer Genome Sequencing (PE-CGS): Research Centers (U2C Clinical Trial Optional) | RFA-CA-19-045 | 10/30/2019 |
| Direct Patient Engagement Network | Patient Engagement and Cancer Genome Sequencing (PE-CGS): Coordinating Center (U24 Clinical Trial Not Allowed) | RFA-CA-19-046 | 10/30/2019 |
| Cancer Immunotherapy Translational Science Network | Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01) | PAR-17-245 | Multiple |
| Cancer Immunotherapy Translational Science Network | Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01) | PAR-17-244 | Multiple |
| Cancer Immunotherapy Translational Science Network | Metabolic Reprogramming to Improve Immunotherapy (R21) | PAR-16-229 | Multiple |
| Cancer Immunotherapy Translational Science Network | Metabolic Reprogramming to Improve Immunotherapy (R01) | PAR-16-228 | Multiple |
| Drivers of Childhood Cancers | Gene Fusions in Pediatric Sarcomas (R21) | PA-16-252 | Multiple |
| Drivers of Childhood Cancers | Gene Fusions in Pediatric Sarcomas (R01) | PA-16-251 | Multiple |
| Generation of Human Tumor Atlases | Emerging Questions in Cancer Systems Biology (U01) | PAR-16-131 | Multiple |
| Therapeutic Target Identification to Overcome Resistance | Revision Applications for Mechanisms of Cancer Drug Resistance (R01 Clinical Trial Not Allowed) | RFA-CA-19-049 | Multiple |
| Symptom Management Research | Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors | RFA-CA-19-033 | 01/03/2020 |